ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 186 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $851,000 | +11.5% | 236,634 | +141.7% | 0.04% | +25.0% |
| Q2 2016 | $763,000 | +77.4% | 97,900 | +145.4% | 0.04% | +38.5% |
| Q4 2015 | $430,000 | +200.7% | 39,900 | +92.8% | 0.03% | +136.4% |
| Q3 2015 | $143,000 | -25.5% | 20,700 | +6.2% | 0.01% | -38.9% |
| Q1 2015 | $192,000 | -69.6% | 19,500 | -69.2% | 0.02% | -85.2% |
| Q3 2014 | $631,000 | -2.0% | 63,300 | -25.6% | 0.12% | +6.1% |
| Q2 2014 | $644,000 | – | 85,100 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
| RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
| ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
| RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
| DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
| Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
| SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
| Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |